Bookrunner
Guardian Pharmacy Services, Inc.
Equity Capital Markets
Initial Public Offering
Transaction Details
On September 25, 2024, Guardian Pharmacy Services, Inc. (“Guardian” or the “Company”) announced the upsizing and pricing of its initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $14.00 per share
- Company also granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Class A common stock
- Guardian shares are expected to begin trading on the New York Stock Exchange (“NYSE”) on September 26, 2024, under the ticker symbol “GRDN”
About the company
Guardian Pharmacy Services (NYSE: GRDN) is a leading long-term care pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. As of June 30, 2024, Guardian’s 50 pharmacies served approximately 174,000 residents in approximately 6,700 LTCFs across 36 states.
Sources: Company filings and press release.
-
This material has been prepared solely for informative purposes as of its date of preparation. It is not a solicitation, recommendation or offer to buy or sell any security and does not provide information on which an investment decision to purchase or sell any securities could be based. It does not purport to be a complete description of the securities, markets or developments referred to in the material. Information included in the material was obtained from sources that we consider reliable, but we have not independently verified such information and do not guarantee that it is accurate or complete. No subsequent publication or distribution of this material shall mean or imply that any such information remains current at any time after the date of preparation of the material. We do not undertake to advise you of any changes in any such information or opinion. Additional information is available upon request.
The offering of these securities is being made only by means of a prospectus, copies of which may be obtained from Stephens Inc.’s Equity Syndicate Desk, at Stephens Inc., 111 Center Street, Little Rock, AR 72201, ATTN: Equity Syndicate Desk, or from the Securities and Exchange Commission’s website at www.sec.gov at the following link:
https://www.sec.gov/Archives/edgar/data/1802255/000119312523250013/d492014ds1.htm
as supplemented by https://www.sec.gov/Archives/edgar/data/1802255/000119312524219380/d856029d424a.htm. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. No offer to buy the securities can be accepted and no part of the purchase price can be received until the registration statement has become effective, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to the notice of its acceptance given after the effective date.“Stephens” (the company brand name) is a leading family-owned investment firm that includes Stephens Inc. (member NYSE/SIPC), Stephens Investment Management Group, LLC, Stephens Insurance, LLC, Stephens Capital Partners LLC and Stephens Europe Limited (Registered office: 12 Arthur Street, London, EC4R 9AB, Registered number 8817024), which is authorised and regulated by the Financial Conduct Authority. © 2024 Stephens.